SAN DIEGO & LONDON--(BUSINESS WIRE)--Human Longevity, Inc. (“HLI”), built by the pioneers of the human genome sequencing effort, and Freedom Acquisition I Corporation (“Freedom”) (NYSE: FACT), a publicly traded special purpose acquisition company, announced t…